l carnitine usage in treatment of acute valproic acid intoxication L-carnitine for valproic-acid induced toxicity Full article: Valproic acid poisoning:

10.1073/pnas.1316569111 Summary Keywords trimethylamine N-oxide, chronic kidney disease, gut microbiota, targeted TMAO drugs, mechanism, treatment Citation Zixin Y, Lulu C, Xiangchang Z, Qing F, Binjie Z, Chunyang L, Tai R and Dongsheng O (2022) TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review

doi: 10.1016/j.ebiom.2018.01.015

A synergistic blend designed to target fat oxidation and energy

Tang WHW, Lemaitre RN, Jensen PN, Wang M, Wang Z, Li XS, et al

Advancements in formulation efficiency and diversified product offerings are expected to strengthen market positioning over the next decade